2-143947125-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001376312.2(GTDC1):c.1304C>T(p.Ala435Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000616 in 1,460,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001376312.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTDC1 | NM_001376312.2 | c.1304C>T | p.Ala435Val | missense_variant | 12/12 | ENST00000682281.1 | NP_001363241.1 | |
LOC101928386 | NR_110237.1 | n.721+5961G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTDC1 | ENST00000682281.1 | c.1304C>T | p.Ala435Val | missense_variant | 12/12 | NM_001376312.2 | ENSP00000507713 | P1 | ||
ENST00000422799.1 | n.715+5961G>A | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249982Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135252
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460718Hom.: 0 Cov.: 29 AF XY: 0.00000826 AC XY: 6AN XY: 726802
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 01, 2024 | The c.1304C>T (p.A435V) alteration is located in exon 12 (coding exon 9) of the GTDC1 gene. This alteration results from a C to T substitution at nucleotide position 1304, causing the alanine (A) at amino acid position 435 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at